Study protocol for the balanced solution versus saline in intensive care study (BaSICS): A factorial randomised trial

Critical Care and Resuscitation

Volumn 19, Issue 2, 2017, Pages 175-182

  Zampieri, Fernando G ^a   Azevedo, Luciano C P ^b,c   Corrêa, Thiago D ^d   Falavigna, Maicon ^e   Machado, Flavia R ^f   De Assunção, Murillo S C ^d   Lobo, Suzana M A ^g   Dourado, Letícia K ^a   Berwanger, Otavio ^a   Kellum, John A ^h   Brandão, Nilton ⁱ   Cavalcanti, Alexandre B ^a  

^a Brazilian Association of Clinical Engineering   (Brazil)

^b HOSPITAL SÍRIO LIBANÊS   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

^e HOSPITAL MOINHOS DE VENTO   (Brazil)

^f FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^g Faculty of Medicine   (Brazil)

^h UNIVERSITY OF PITTSBURGH   (United States)

ⁱ UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID; ACETIC ACID PLUS GLUCONATE SODIUM PLUS MAGNESIUM CHLORIDE PLUS POTASSIUM CHLORIDE PLUS SODIUM CHLORIDE; GLUCONIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM CHLORIDE;

AGED; BRAZIL; CAUSE OF DEATH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICAL ILLNESS; DOUBLE BLIND PROCEDURE; FLUID THERAPY; HOSPITAL MORTALITY; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; MORTALITY; MULTICENTER STUDY; PATIENT SELECTION; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

AGED; BRAZIL; CAUSE OF DEATH; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; FLUID THERAPY; GLUCONATES; HOSPITAL MORTALITY; HUMANS; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS; MAGNESIUM CHLORIDE; PATIENT SELECTION; POTASSIUM CHLORIDE; RESEARCH DESIGN; SODIUM ACETATE; SODIUM CHLORIDE;

EID: 85023738678     PISSN: 14412772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Cecconi M, Hofer C, Teboul J-L, et al. Fluid challenges in intensive care: the FENICE study: a global inception cohort study. Intensive Care Med 2015; 41: 1529-37.
2. Zhou F, Peng Z-Y, Bishop JV, et al. Effects of fluid resuscitation with 0.9% saline versus a balanced electrolyte solution on acute kidney injury in a rat model of sepsis. Crit Care Med 2014; 42: e270-8.
3. Rochwerg B, Alhazzani W, Sindi A, et al. Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med 2014; 161: 347-55.
4. Shaw AD, Schermer CR, Lobo DN, et al. Impact of intravenous fluid composition on outcomes in patients with systemic inflammatory response syndrome. Crit Care 2015; 19: 334.
5. Zampieri FG, Ranzani OT, Azevedo LCPC, et al. Lactated Ringer is associated with reduced mortality and less acute kidney injury in critically ill patients: a retrospective cohort analysis. Crit Care Med 2016; 44: 2163-70.
6. Raghunathan K, Shaw A, Nathanson B, et al. Association between the choice of IV crystalloid and in-hospital mortality among critically ill adults with sepsis. Crit Care Med 2014; 42: 1585-91.
7. Neyra JA, Canepa-Escaro F, Li X, et al. Association of hyperchloremia with hospital mortality in critically ill septic patients. Crit Care Med 2015; 43: 1938-44.
8. Nadeem A, Salahuddin N, El Hazmi A, et al. Chloride-liberal fluids are associated with acute kidney injury after liver transplantation. Crit Care 2014; 18: 625.
9. Young P, Bailey M, Beasley R, et al. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit. JAMA 2015; 314: 1701-10.
10. Maitland K, Kiguli S, Opoka RO, et al. Mortality after fluid bolus in African children with severe infection. N Engl J Med 2011; 364: 2483-95.
11. Maitland K, George EC, Evans JA, et al. Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial. BMC Med 2013; 11: 68.
12. Monge García MI, Guijo González P, Gracia Romero M, et al. Effects of fluid administration on arterial load in septic shock patients. Intensive Care Med 2015; 41: 1247-55.
13. Aung NM, Kaung M, Kyi TT, et al. The safety of a conservative fluid replacement strategy in adults hospitalised with malaria. PLoS One 2015; 10: e0143062.
14. Silversides JA, Major E, Ferguson AJ, et al. Conservative fluid management or deresuscitation for patients with sepsis or acute respiratory distress syndrome following the resuscitation phase of critical illness: a systematic review and meta-analysis. Intensive Care Med 2016; 43: 155-170.
15. Gaudry S, Hajage D, Schortgen F, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 2016; 375: 122-33.
16. Kellum JA, Lameire N. Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013; 17: 204.
17. Vincent JL, Moreno R, Takala J, et al; Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure.. Intensive Care Med 1996; 22: 707-10.
18. Soares M, Bozza FA, Angus DC, et al. Organizational characteristics, outcomes, and resource use in 78 Brazilian intensive care units: the ORCHESTRA study. Intensive Care Med 2015; 41: 2149-60.
19. Cavalcanti AB, Bozza FA, Machado FR, et al; Writing Group for the CHECKLIST-ICU Investigators and the Brazilian Research in Intensive Care Network (BRICNet). Effect of a quality improvement intervention with daily round checklists, goal setting, and clinician prompting on mortality of critically ill patients: a randomized clinical trial. JAMA 2016; 315: 1480-90.
20. Montori VM, Devereaux PJ, Adhikari NKJ, et al. Randomized trials stopped early for benefit: a systematic review. JAMA 2005; 294: 2203-9.
21. Mueller PS, Montori VM, Bassler D, et al. Ethical issues in stopping randomized trials early because of apparent benefit. Ann Intern Med 2007; 146: 878-81.
22. Francis D, Roberts I, Elbourne DR, et al. Marketing and clinical trials: a case study. Trials 2007; 8: 37.
23. Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Rev Panam Salud Publica 2015; 38: 506-14.